RV Fractional Area Change and TAPSE as Predictors of Severe Right Ventricular Dysfunction in Pulmonary Hypertension: A CMR Study

被引:54
|
作者
Hoette, Susana [1 ]
Creuze, Nicolas [2 ]
Gunther, Sven [3 ]
Montani, David [3 ]
Savale, Laurent [3 ]
Jais, Xavier [3 ]
Parent, Florence [3 ]
Sitbon, Olivier [3 ]
Rochitte, Carlos Eduardo [4 ]
Simonneau, Gerald [3 ]
Humbert, Marc [3 ]
Souza, Rogerio [1 ]
Chemla, Denis [2 ]
机构
[1] Univ Sao Paulo, Inst Heart, Dept Pulm, Sch Med, Ave Dr Eneas de Carvalho Aguiar,44, BR-05403000 Sao Paulo, Brazil
[2] APHP, Physiol & Radiol, Fac Med Paris 11, EA4533, Le Kremlin Bicetre, France
[3] Paris11 Univ, APHP, Pneumol, Inserm,UMR S999, Le Kremlin Bicetre, France
[4] Univ Sao Paulo, Inst Heart, Cardiovasc Imaging, Sch Med, Sao Paulo, Brazil
关键词
Right ventricular dysfunction; Pulmonary hypertension; Cardiac ventricles; Hemodynamics; RVFAC; TAPSE; CARDIAC MAGNETIC-RESONANCE; TRICUSPID ANNULAR MOTION; ARTERIAL-HYPERTENSION; THERAPY; HEMODYNAMICS; PRESSURE; SURVIVAL; MRI;
D O I
10.1007/s00408-018-0089-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
The right ventricular ejection fraction (RVEF) is a surrogate marker of right ventricular function in pulmonary hypertension (PH), but its measurement is complicated and time consuming. The tricuspid annular plane systolic excursion (TAPSE) measures only the longitudinal component of RV contraction while the right ventricular fractional area change (RVFAC) takes into account both the longitudinal and the transversal components. The aim of our study was to evaluate the relationship between RVEF, RVFAC, and TAPSE according to hemodynamic severity in two groups of patients with PH: pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH). Fifty-four patients with PAH (n = 15) and CTEPH (n = 39) underwent right heart catheterization and cardiac magnetic resonance (CMR). The ventricular volumes and areas, TAPSE, and eccentricity index were measured. The RVFAC was more strongly correlated with the RVEF (r = 0.81, p < 0.0001) than the TAPSE (r = 0.63, p < 0.0001). RVEF < 35% was better predicted by the RVFAC than the TAPSE (TAPSE: AUC = 0.77 and RVFAC: AUC = 0.91; p = 0.042). In the group with the worse hemodynamic status, the RVFAC correlated much better with the RVEF than the TAPSE. There were no significant differences in the CMR data analyzed between the groups of PAH and CETPH patients. The RVFAC is a good index to estimate RVEF in PH patients; even better than the TAPSE in patients with more severe hemodynamic profile, possibly for including the transversal component of right ventricular function in its measurement. Furthermore, RVFAC performance was similar in the two PH groups (PAH and CTEPH).
引用
收藏
页码:157 / 164
页数:8
相关论文
共 50 条
  • [41] Intravenous sildenafil in right ventricular dysfunction with pulmonary hypertension following a heart transplant
    Almenar Bonet, Luis
    Vicente Guillen, Rosario
    Sanchez Lazaro, Ignacio
    de la Fuente, Carmen
    Osseyran, Faisa
    Martinez Dolz, Luis
    Montero Hernandez, Monica
    Portoles Sanz, Manuel
    Rivera Otero, Miguel
    Salvador Sanz, Antonio
    HEART INTERNATIONAL, 2014, 9 (01): : 22 - 25
  • [42] The cell and molecular biology of right ventricular dysfunction in pulmonary hypertension
    Haworth, Sheila G.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2007, 9 (0H) : H10 - H16
  • [43] Right and left ventricular dysfunction in patients with severe pulmonary disease
    Vizza, CD
    Lynch, JP
    Ochoa, LL
    Richardson, G
    Trulock, EP
    CHEST, 1998, 113 (03) : 576 - 583
  • [44] Right ventricular dysfunction in pulmonary hypertension with combined pulmonary fibrosis and emphysema syndrome
    Swift, Andrew
    Rajaram, Smitha
    Capener, Dave
    Hill, Catherine
    Davies, Christine
    Hurdman, Judith
    Condliffe, Robin
    Elliot, Charlie
    Kiely, David
    Wild, Jim
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [45] Differences in right ventricular dysfunction in patients with idiopathic pulmonary hypertension versus secondary pulmonary hypertension
    Emami, Sepideh
    Samiei, Niloufar
    Amin, Ahamd
    Taghavi, Sepideh
    Parsaee, Mozhghan
    Naderi, Nasim
    Serati, Alireza
    Movahed, Mohammad Reza
    ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (01) : 1 - 5
  • [46] Exercise cardiac MRI unmasks right ventricular dysfunction in acute hypoxia and chronic pulmonary arterial hypertension
    Jaijee, Shareen
    Quinlan, Marina
    Tokarczuk, Pawel
    Clemence, Matthew
    Howard, Luke S. G. E.
    Gibbs, J. Simon R.
    O'Regan, Declan P.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2018, 315 (04): : H950 - H957
  • [47] Contribution of Impaired Parasympathetic Activity to Right Ventricular Dysfunction and Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension
    Bos, Denielli da Silva Goncalves
    Van Der Bruggen, Cathelijne E. E.
    Kurakula, Kondababu
    Sun, Xiao-Qing
    Casali, Karina R.
    Casali, Adenauer G.
    Rol, Nina
    Szulcek, Robert
    dos Remedios, Cris
    Guignabert, Christophe
    Tu, Ly
    Dorfmueller, Peter
    Humbert, Marc
    Wijnker, Paul J. M.
    Kuster, Diederik W. D.
    van der Velden, Jolanda
    Goumans, Marie-Jose
    Bogaard, Harm-Jan
    Vonk-Noordegraaf, Anton
    de Man, Frances S.
    Handoko, M. Louis
    CIRCULATION, 2018, 137 (09) : 910 - 924
  • [48] Effect of warfarin on survival in patients with concomitant left ventricular systolic dysfunction and pulmonary hypertension: a population cohort study
    Goudie, Andrew
    Elder, Douglas
    Deshmukh, Harshal
    Szwejkowski, Benjamin R.
    Lang, Chim C.
    George, Jacob
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (01) : 90 - 97
  • [49] Computed tomographic pulmonary angiography in the assessment of severity of chronic thromboembolic pulmonary hypertension and right ventricular dysfunction
    Liu, Min
    Ma, Zhanhong
    Guo, Xiaojuan
    Zhang, Hongxia
    Yang, Yuanhua
    Wang, Chen
    EUROPEAN JOURNAL OF RADIOLOGY, 2011, 80 (03) : E462 - E469
  • [50] Isolated right ventricular dysfunction in systemic sclerosis:: latent pulmonary hypertension?
    Huez, S.
    Roufosse, F.
    Vachiery, J-L.
    Pavelescu, A.
    Derumeaux, G.
    Wautrecht, J-C.
    Cogan, E.
    Naeije, R.
    EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) : 928 - 936